BioCentury
ARTICLE | Clinical News

CLBS03: Ph II ongoing

November 2, 2016 11:08 PM UTC

An independent DSMB recommended continuation to the second cohort of the double-blind, placebo-controlled, U.S. Phase II T-Rex trial evaluating single infusions of 2 dose levels of CLBS03 in patients ...

BCIQ Company Profiles

Caladrius Biosciences Inc.